In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Glasshouse Pharmaceuticals Limited Canada |
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc., Mylan Inc., Perrigo Pharma International DAC, Aleor Dermaceuticals Limited, Ascent Pharmaceuticals, Inc., FlatWing Pharmaceuticals, LLC, Lupin Pharmaceuticals, Inc., Apotex Corp., Taro Pharmaceutical Industries, Ltd., Lupin Limited, Cipla USA, Inc., Encube Ethicals Pvt. Ltd., Perrigo Company plc, Cadila Healthcare Ltd., Amneal Pharmaceuticals LLC, Clerk of MDL Panel, Apotex Inc., Cipla Limited and Mylan Pharmaceuticals Inc. |
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation |
Anacor Pharmaceuticals, Inc. |
1:2019md02884 |
April 3, 2019 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on December 27, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 73 NOTICE requesting Clerk to remove Jeremy S. Cole as co-counsel. Reason for request: Leaving Firm. (Cole, Jeremy) |
Filing 72 NOTICE of Appearance by Damien Nicholas Tancredi on behalf of Cipla Limited, Cipla USA, Inc. (Tancredi, Damien) |
Filing 71 NOTICE requesting Clerk to remove Paul B. Sudentas as co-counsel. Reason for request: no longer with Locke Lord LLP. (Kraman, Pilar) |
Filing 70 SO ORDERED Granting (D.I. 69 in 19-md-2884-RGA; D.I. 77 in 1:19-cv-00632-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 10/25/2019. Associated Cases: 1:19-md-02884-RGA, 1:19-cv-00632-RGA(nms) |
Filing 69 STIPULATION of Dismissal without prejudice, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/24/2019 (nms). |
Filing 68 NOTICE requesting Clerk to remove David A. Gerasimow as co-counsel. Reason for request: No longer with Husch Blackwell LLP. (Haney, Megan) |
Filing 67 ORDER: The cases are ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the "Federal Circuit" has resolved the appeal so that these case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 66 ORDER TO STAY: The actions are stayed pending Plaintiff's appeal of the PTAB Decisions to the Federal Circuit. The parties will notify the Court of the Federal Circuit's decision no later than three (3) days after it issues. The parties should be prepared to submit with the notification their requests for how to proceed. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 65 Letter to Honorable Richard G. Andrews from Kelly E. Farnan regarding Defendants' Support of Their Stay Proposal. (Attachments: #1 Text of Proposed Order)(Farnan, Kelly) |
Filing 64 Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Stay. (Attachments: #1 Exhibit 1-2)(Dellinger, Megan) |
Filing 63 ORDER re (71 in 19-cv-632-RGA, 129 in 18-cv-1673-RGA, 86 in 18-cv-1606-RGA, 62 in 19-md-2884-RGA) Stipulation and Order to File Competing Stay Proposals. Signed by Judge Richard G. Andrews on 8/27/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 62 STIPULATION and [Proposed] Order to File Competing Stay Proposals by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
SO ORDERED, re (128 in 18-cv-1673-RGA, 85 in 18-cv-1606-RGA, 70 in 19-cv-632-RGA, 61 in 19-md-2884-RGA) Stipulation and Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 8/15/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 61 STIPULATION and Order to Amend Scheduling Order by Anacor Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
SO ORDERED, re (84 in 18-cv-1606-RGA, 59 in 19-md-2884-RGA, 127 in 18-cv-1673-RGA, 68 in 19-cv-632-RGA) Stipulation and Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 8/8/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 60 NOTICE requesting Clerk to remove Anjali Deshmukh as co-counsel. Reason for request: no longer with the firm Wilson Sonsini Goodrich and Rosati. (Palapura, Bindu) |
Filing 59 STIPULATION to Amend Scheduling Order by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
Filing 58 STIPULATION TO EXTEND TIME re: Protective Order to and including August 14, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
SO ORDERED, re (67 in 19-cv-632-RGA, 126 in 18-cv-1673-RGA, 58 in 19-md-2884-RGA, 83 in 18-cv-1606-RGA) STIPULATION TO EXTEND TIME to submit proposed Protective Order to August 14, 2019. Signed by Judge Richard G. Andrews on 7/31/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
SO ORDERED, re (57 in 19-md-2884-RGA, 125 in 18-cv-1673-RGA, 82 in 18-cv-1606-RGA, 66 in 19-cv-632-RGA) Stipulation and Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 7/25/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 57 STIPULATION and Order to Amend Scheduling Order by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
Filing 56 NOTICE OF SERVICE of core technical documents (bates numbers ASC_TAV0000001-0002838) filed by Ascent Pharmaceuticals, Inc..(Rogowski, Patricia) |
Filing 55 NOTICE OF SUBSTITUTION OF COUNSEL re Ascent Pharmaceuticals, Inc.: Entry of appearance of attorney Patricia Smink Rogowski. Attorney R. Touhey Myer and Salvatore Guerriero terminated. (Rogowski, Patricia) |
Filing 54 ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 7/18/2019. (dlb) |
SO ORDERED, re (65 in 19-cv-632-RGA, 53 in 19-md-2884-RGA, 122 in 18-cv-1673-RGA, 81 in 18-cv-1606-RGA) STIPULATION TO EXTEND TIME to file a protective order to July 31, 2019. Signed by Judge Richard G. Andrews on 7/17/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 53 STIPULATION TO EXTEND TIME to file a protective order to July 31, 2019 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 7/17/2019 (nms). |
Filing 52 NOTICE OF SERVICE of Defendant Flatwing Pharmaceuticals, LLC's Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Defendant Flatwing Pharmaceuticals, LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by FlatWing Pharmaceuticals, LLC.(Phillips, John) |
Filing 51 NOTICE of Withdrawal of Counsel, Michelle M. Ovanesian by Perrigo Company plc, Perrigo Pharma International DAC (Higgins, James) |
Filing 50 NOTICE OF SERVICE of (1) Apotex's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Apotex's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
ORDER re (119 in 18-cv-1673-RGA, 64 in 19-cv632-RGA, 49 in 19-md-2884-RGA, 79 in 18-cv-1606-RGA) Stipulation and Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/25/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 49 STIPULATION and Order to Amend Scheduling Order by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
SO ORDERED, re (47 in 19-md-2884-RGA, 117 in 18-cv-1673-RGA) STIPULATION TO EXTEND TIME for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019. Signed by Judge Richard G. Andrews on 6/13/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01673-RGA(nms) |
Filing 48 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
Filing 47 STIPULATION TO EXTEND TIME for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
Filing 46 STIPULATION TO EXTEND TIME Proposed Protective Order to and including June 27, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
SO ORDERED, re (78 in 18-cv-1606-RGA, 116 in 18-cv-1673-RGA, 46 in 19-md-2884-RGA, 63 in 19-cv-632-RGA) STIPULATION TO EXTEND TIME Proposed Protective Order to and including June 27, 2019. Signed by Judge Richard G. Andrews on 6/13/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
SO ORDERED, re (118 in 18-cv-1673-RGA, 48 in 19-md-2884-RGA) MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 6/13/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01673-RGA(nms) |
Pro Hac Vice Attorney Joseph M. Janusz for Apotex Corp., for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
Filing 45 SO ORDER Granting (75 in 18-cv-1606-RGA, 43 in 19-md-2884-RGA) Stipulation of Dismissal (*Glasshouse Pharmaceuticals Limited Canada terminated). Signed by Judge Richard G. Andrews on 6/11/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA(nms) |
Filing 44 STIPULATION TO EXTEND TIME Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
SO ORDERED, re (76 in 18-cv-1606-RGA, 44 in 19-md-2884-RGA) STIPULATION TO EXTEND TIME Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019. Signed by Judge Richard G. Andrews on 6/11/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA(nms) |
Filing 43 STIPULATION and Order of Dismissal, by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 6/11/2019 (nms). |
Filing 42 NOTICE of Withdrawal of Christine M. Braswell as Counsel by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Kraman, Pilar) |
Filing 41 SO ORDERED Granting (40 in 19-md-2884-RGA, 113 in 18-cv-1673-RGA) Stipulation of Dismissal (*Parties Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., terminated). Signed by Judge Richard G. Andrews on 6/3/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01673-RGA(nms) |
Filing 40 STIPULATION of Dismissal by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
Filing 39 NOTICE OF SERVICE of (1) Initial Disclosures under Rule 26(a)(1) and (2) Initial Disclosures under Paragraph 3 of the Default Standard for Discovery filed by Cipla Limited, Cipla USA, Inc..(Cole, Jeremy) |
SO ORDERED, re (72 in 18-cv-1606-RGA, 32 in 19-md-2884-RGA, 61 in 19-cv-632-RGA, 106 in 18-cv-1673-RGA) STIPULATION TO EXTEND TIME Deadline for the Parties to Submit a Proposed Protective Order to June 13, 2019. Signed by Judge Richard G. Andrews on 5/30/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
CORRECTING ENTRY: The pdf for D.I. 29 has been replaced with an amended version. The caption on the filing has been corrected. (nms) |
Filing 38 NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limiteds Fed. R. Civ. P. 26(a)(1) Initial Disclosures; and 2) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limiteds Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Braswell, Christine) |
Filing 37 NOTICE OF SERVICE of Defendant Encube Ethicals Pvt. Ltd.'s: (1) Initial Disclosures Under Rule 26(a)(1) and (2) Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Encube Ethicals Pvt. Ltd..(Farnan, Kelly) |
Filing 36 NOTICE OF SERVICE of (1) Defendants Taro Pharmaceuticals U.S.A. and Taro Pharmaceutical Industries, Ltd. Initial Disclosures Under Rule 26(a)(1) and (2) Defendants Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Farnan, Kelly) |
Filing 35 NOTICE OF SERVICE of 1) Defendant Amneal Pharmaceuticals LLC's Initial Disclosures Under Paragraph 3 of the District of Delaware's Default Standard for Discovery, Including Electronically Stored Information ("ESI") and 2) Defendant Amneal Pharmaceuticals LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Amneal Pharmaceuticals LLC.(Gaza, Anne) |
Filing 34 NOTICE OF SERVICE of (1) Anacor's Rule 26(a) Initial Disclosures and (2) Anacor's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) |
Filing 33 NOTICE OF SERVICE of Initial Disclosures of Perrigo Pharma International DAC and Perrigo Company plc filed by Perrigo Company plc, Perrigo Pharma International DAC.(Ovanesian, Michelle) |
Filing 32 STIPULATION TO EXTEND TIME Deadline for the Parties to Submit a Proposed Protective Order to June 13, 2019 - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Ovanesian, Michelle) |
Filing 31 NOTICE OF SERVICE of Defendant Aleor Dermaceuticals Limiteds Initial Disclosures Pursuant to Delawares Default Standard for Discovery and Defendant Aleor Dermaceuticals Limiteds Initial Disclosures filed by Aleor Dermaceuticals Limited.(Harmon, Kate) |
Filing 30 NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and Mylan Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and the District of Delaware's Default Standard for Discovery filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
Filing 29 NOTICE OF SERVICE of Ascent Pharm., Inc.s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Ascent Pharm., Inc.s Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ascent Pharmaceuticals, Inc..(Myer, R.) (Main Document 29 replaced on 5/31/2019) (nms). |
Filing 28 NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Mowery, Katharine) |
Filing 27 STIPULATION TO EXTEND TIME deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 13, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
Filing 26 STIPULATION and [Proposed] Order to Extend Time, by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 5/30/2019 (nms). |
SO ORDERED, re (103 in 18-cv-1673-RGA, 27 in 19-md-2884-RGA) STIPULATION TO EXTEND TIME deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 13, 2019. Signed by Judge Richard G. Andrews on 5/30/2019. Associated Cases: 1:18-cv-01673-RGA, 1:19-md-02884-RGA(nms) |
SO ORDERED, re (70 in 18-cv-1606-RGA, 26 in 19-md-2884-RGA) Stipulation and Order to Extend Time. Signed by Judge Richard G. Andrews on 5/30/2019. Associated Cases: 1:18-cv-01606-RGA, 1:19-md-02884-RGA(nms) |
SO ORDERED, re (25 in 19-md-2884-RGA, 69 in 18-cv-1606-RGA) STIPULATION TO EXTEND TIME extend deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 11, 2019. Signed by Judge Richard G. Andrews on 5/30/2019. Associated Cases: 1:18-cv-01606-RGA, 1:19-md-02884-RGA(nms) |
Filing 25 STIPULATION TO EXTEND TIME extend deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 11, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
SO ORDERED, re (102 in 18-cv-1673-RGA, 24 in 19-md-2884-RGA) STIPULATION to Extend Deadlines. Signed by Judge Richard G. Andrews on 5/29/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01673-RGA(nms) |
Filing 24 STIPULATION to Extend Deadlines - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 5/29/2019 (nms). |
Filing 23 ANSWER to #18 Counterclaims, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 5/20/2019 (nms). |
Filing 22 Official Transcript of Scheduling Conference held on 4/25/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/5/2019. Redacted Transcript Deadline set for 6/17/2019. Release of Transcript Restriction set for 8/13/2019. (Triozzi, Heather) |
Filing 21 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/20/2019. Amended Pleadings due by 12/20/2019. Fact Discovery completed by 7/31/2020. Status Report due by 7/31/2020. Joint Claim Construction Brief due by 3/12/2020. A Markman Hearing is set for 4/13/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/26/2021, at 9:00 AM in Courtroom 6A. A 3-5 day Bench Trial is set to begin 4/12/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 4/30/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
Filing 20 Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Revised Proposed Scheduling Order. (Attachments: #1 Revised Proposed Scheduling Order)(Dellinger, Megan) |
Filing 19 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Contract Pharmaceuticals Limited for Glasshouse Pharmaceuticals Limited Canada filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
Filing 18 ANSWER to Complaint, Affirmative Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Glasshouse Pharmaceuticals Limited Canada.(Fry, David) Modified on 4/29/2019 (nms). |
Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 4/25/2019. Local counsel present for plaintiff: M. Dellinger. Local counsel present for defendants: P. Kraman, A. Gaza, K. Farnan, D. Moore, K. Mowery, N. Hoeschen, R. Touhey Myer, M. Haney, K. Harmon, K. Dorsney, S. Coyle. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(crb) |
Filing 17 MOTION for Pro Hac Vice Appearance of Attorney Steven Coyle, Andrew Ryan and Nicholas Geiger - filed by Cipla Limited, Cipla USA, Inc.. (Attachments: #1 Affidavit Andrew Ryan, #2 Affidavit Nicholas Geiger, #3 Affidavit Steven Coyle)(Cole, Jeremy) |
Filing 16 NOTICE of Appearance by Jeremy S. Cole on behalf of Cipla Limited, Cipla USA, Inc. (Cole, Jeremy) |
Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Margolis - filed by Glasshouse Pharmaceuticals Limited Canada. (Hoeschen, Nathan) |
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Mark T. Deming, Helena Berezowskyj, and John P. Snow, filed by Perrigo Pharma International DAC, Perrigo Company plc. Signed by Judge Richard G. Andrews on 4/24/2019. (nms) |
SO ORDERED, re #17 MOTION for Pro Hac Vice Appearance of Attorney Steven Coyle, Andrew Ryan and Nicholas Geiger, filed by Cipla Limited, Cipla USA, Inc.. Signed by Judge Richard G. Andrews on 4/24/2019. (nms) |
SO ORDERED, re #15 MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Margolis, filed by Glasshouse Pharmaceuticals Limited Canada. Signed by Judge Richard G. Andrews on 4/24/2019. (nms) |
Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Mark T. Deming, Helena Berezowskyj, and John P. Snow - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Attachments: #1 Certification by Counsel)(Higgins, James) |
Filing 13 Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Scheduling Order. (Attachments: #1 Proposed Order)(Dellinger, Megan) Modified on 4/24/2019 (nms). |
Filing 12 NOTICE of Appearance by Christine M. Braswell on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Braswell, Christine) |
Filing 11 NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) |
Filing 10 NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Moore, David) |
Filing 9 STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2019. Signed by Judge Richard G. Andrews on 4/15/2019. (nms) |
Filing 8 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 18, 2018. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
Filing 7 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
Filing 6 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
Filing 5 NOTICE of Appearance of Jack B. Blumenfeld, Megan E. Dellinger and the Law Firm of Morris, Nichols, Arsht & Tunnell LLP by Anacor Pharmaceuticals, Inc. (Dellinger, Megan) |
Filing 4 ORAL ORDER: A Scheduling Conference is now set for 4/25/2019, at 3:00 PM in Courtroom 6A before Judge Richard G. Andrews. The parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent form. Ordered by Judge Richard G. Andrews on 4/5/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
Filing 3 Letter to the Clerk of USDC/WV, dated 4/4/2019, from the Clerk of USDC/DE, regarding transfer of case 18cv202-IMK. (nmg) Modified on 4/4/2019 (nms). |
Remark: The following cases in the District of Delaware are included in this MDL: 1:18-cv-01606-RGA, 1:18-cv-01673-RGA and 1:19-cv-00632-RGA (nmg) |
Filing 2 NOTICE TO COUNSEL: MDL No. 1:19-md-2884 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
Filing 1 CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 4/3/19. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.